Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

Breast cancer screening and overdiagnosis.

Bulliard JL, Beau AB, Njor S, et al. Breast cancer screening and overdiagnosis. Int J Cancer. 2021;149(4): 846-853. doi: 10.1002/ijc.33602.

Save
Print
August 11, 2021
Bulliard J‐L, Beau A‐B, Njor S, et al. Int J Cancer. 2021;149(4):846-853.
View more articles from the same authors.

Overdiagnosis of breast cancer and the resulting overtreatment can cause physical, emotional, and financial harm to patients. Analysis of observational data and modelling indicates overdiagnosis accounts for less than 10% of invasive breast cancer in patients aged 50-69. Understanding rates of overdiagnosis can assist in ascertaining the net benefit of breast cancer screening.

Save
Print
Cite
Citation

Bulliard JL, Beau AB, Njor S, et al. Breast cancer screening and overdiagnosis. Int J Cancer. 2021;149(4): 846-853. doi: 10.1002/ijc.33602.

Related Resources From the Same Author(s)
Related Resources